Single chain trimers and uses therefor
AssigneeWashington University
InventorsTed Hansen, Yik Yeung Lawrence Yu
Life of this patent
Estimating the term…
Loading patent…
AssigneeWashington University
InventorsTed Hansen, Yik Yeung Lawrence Yu
Estimating the term…
Single chain trimer (SCT) molecules are disclosed, comprising an MHC antigen peptide sequence, a β2-microglobulin sequence and a full-length MHC class I heavy chain sequence, joined by linker sequences. Further described are nucleic acids encoding single chain trimers. Methods for expansion of antigen-specific T cell populations using single chain trimer molecules are also disclosed. In some configurations, these methods comprise co-culturing, in a first stage, CD8+ T cells from a donor with antigen presenting cells comprising an MHC antigen peptide, and co-culturing, in a second stage, the CD8+ T cells with cells comprising an SCT which has an MHC antigen peptide sequence identical to the sequence of the antigen peptide in the first stage. The methods can provide 10,000-100,000 fold expansion of antigen-specific CD8+ T cells within about 28 days after establishing culture, and can yield over 1 billion antigen-specific CD8+ T cells expanded from an individual donor.
A single chain trimer molecule comprising, in amino-to-carboxy terminal order, an antigen peptide sequence, a first flexible linker sequence, a β2-microglobulin sequence, a second flexible linker sequence and a human MHC class I heavy chain sequence wherein the MHC class I heavy chain sequence comprises a mutation of tyrosine-84 to a non-aromatic amino acid other than proline.
Dependencies are inferred from the claim text.